Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2003

View Archived Issues

Company profile: Enact Pharma

Quinoline Src kinase inhibitors in AstraZeneca pipeline

Novel agents for enhancing DNA-damaging antitumor activity

Dual 5-HT reuptake inhibitors/5-HT1A agonists discovered at Wyeth

Lilly researchers claim piperidine-containing factor Xa inhibitors

Novel antidiabetic agents covered by Dr. Reddy's patent

Merck presents new aldose reductase inhibitors

Novel series of antiangiogenic tyrosine kinase inhibitors for cancer and other disorders

Merck presents new antithrombotic thrombin receptor antagonists

BMS claims buspirone metabolite enantiomers with utility in anxiety and depression

XenoPort receives SBIR grant to aid in identification of drug transport pathways

Schwarz's year-end results exceed expectations

Sumitomo licenses Glucophage in Japan

Vical anthrax vaccine to enter clinical testing by year-end 2003

Potential use of abetimus sodium in the prevention of SLE-associated renal flare

Gadobutrol perfusion-weighted imaging in Alzheimer's disease

Transarterial 131I-lipiodol in HCC

Ariad focuses resources on anticancer candidates

Prevention of angina attacks by ivabradine

ACAM-2000 completes phase I trial

Omalizumab reduces the incidence of exacerbations in allergic asthma

Hybridon's IMO compounds show activity in preclinical models of allergic asthma

Catalyst Pharmaceutical will seek licenses for NM-702

Gadofosveset sodium improves MRA accuracy and patient management in PVD

Promising results emerge from phase II study of DP-b99 in stroke

Boston Scientific and Osiris form stem cell alliance

Mutual recognition procedure successfully completed for Crestor

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...